Large HERCs Function As Tumor Suppressors

Overview

Journal Front Oncol

Specialty Oncology

Date 2019 Jul 6

PMID 31275856

Citations 4

Authors

Taiane Schneider

Arturo Martinez-Martinez

Monica Cubillos-Rojas

Ramon Bartrons

Francesc Ventura

Jose Luis Rosa

Affiliations

Soon will be listed here.

Citing Articles

Regulation of MAPK Signaling Pathways by the Large HERC Ubiquitin Ligases.

Sala-Gaston J, Costa-Sastre L, Pedrazza L, Martinez-Martinez A, Ventura F, Rosa J Int J Mol Sci. 2023; 24(5).

PMID: 36902336 PMC: 10003351. DOI: 10.3390/ijms24054906.

HERC2 deficiency activates C-RAF/MKK3/p38 signalling pathway altering the cellular response to oxidative stress.

Sala-Gaston J, Pedrazza L, Ramirez J, Martinez-Martinez A, Rawlins L, Baple E Cell Mol Life Sci. 2022; 79(11):548.

PMID: 36241744 PMC: 9568463. DOI: 10.1007/s00018-022-04586-7.

Emerging roles of the HECT-type E3 ubiquitin ligases in hematological malignancies.

Delvecchio V, Fierro C, Giovannini S, Melino G, Bernassola F Discov Oncol. 2022; 12(1):39.

PMID: 35201500 PMC: 8777521. DOI: 10.1007/s12672-021-00435-4.

HERC Ubiquitin Ligases in Cancer.

Sala-Gaston J, Martinez-Martinez A, Pedrazza L, Lorenzo-Martin L, Caloto R, Bustelo X Cancers (Basel). 2020; 12(6).

PMID: 32580485 PMC: 7352365. DOI: 10.3390/cancers12061653.

References

Amos C, Wang L, Lee J, Gershenwald J, Chen W, Fang S . Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. Hum Mol Genet. 2011; 20(24):5012-23. PMC: 3298855. DOI: 10.1093/hmg/ddr415. View

Cubillos-Rojas M, Amair-Pinedo F, Peiro-Jordan R, Bartrons R, Ventura F, Rosa J . The E3 ubiquitin protein ligase HERC2 modulates the activity of tumor protein p53 by regulating its oligomerization. J Biol Chem. 2014; 289(21):14782-95. PMC: 4031533. DOI: 10.1074/jbc.M113.527978. View

Uhlen M, Fagerberg L, Hallstrom B, Lindskog C, Oksvold P, Mardinoglu A . Proteomics. Tissue-based map of the human proteome. Science. 2015; 347(6220):1260419. DOI: 10.1126/science.1260419. View

Sanchez-Tena S, Cubillos-Rojas M, Schneider T, Rosa J . Functional and pathological relevance of HERC family proteins: a decade later. Cell Mol Life Sci. 2016; 73(10):1955-68. PMC: 11108380. DOI: 10.1007/s00018-016-2139-8. View

Ferguson R, Vogelsang M, Ucisik-Akkaya E, Rai K, Pilarski R, Martinez C . Genetic markers of pigmentation are novel risk loci for uveal melanoma. Sci Rep. 2016; 6:31191. PMC: 4976361. DOI: 10.1038/srep31191. View

Ping Z, Siegal G, Harada S, Eltoum I, Youssef M, Shen T . ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast. Oncotarget. 2016; 7(49):80655-80663. PMC: 5340256. DOI: 10.18632/oncotarget.13019. View

Cubillos-Rojas M, Schneider T, Bartrons R, Ventura F, Rosa J . NEURL4 regulates the transcriptional activity of tumor suppressor protein p53 by modulating its oligomerization. Oncotarget. 2017; 8(37):61824-61836. PMC: 5617467. DOI: 10.18632/oncotarget.18699. View

Johansson P, Klein-Hitpass L, Choidas A, Habenberger P, Mahboubi B, Kim B . SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia. Blood Cancer J. 2018; 8(1):11. PMC: 5802577. DOI: 10.1038/s41408-017-0036-5. View

Mao X, Sethi G, Zhang Z, Wang Q . The Emerging Roles of the HERC Ubiquitin Ligases in Cancer. Curr Pharm Des. 2018; 24(15):1676-1681. DOI: 10.2174/1381612824666180528081024. View

10.

Schneider T, Martinez-Martinez A, Cubillos-Rojas M, Bartrons R, Ventura F, Rosa J . The E3 ubiquitin ligase HERC1 controls the ERK signaling pathway targeting C-RAF for degradation. Oncotarget. 2018; 9(59):31531-31548. PMC: 6101136. DOI: 10.18632/oncotarget.25847. View